HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Lisa A Carey Selected Research
Lisa A Carey Research Topics
Disease
181
Breast Neoplasms (Breast Cancer)
04/2024 - 09/2002
115
Neoplasms (Cancer)
04/2024 - 09/2002
35
Triple Negative Breast Neoplasms
04/2024 - 10/2008
19
Pathologic Complete Response
03/2024 - 01/2007
16
Brain Neoplasms (Brain Tumor)
01/2023 - 11/2005
16
Neoplasm Metastasis (Metastasis)
01/2023 - 12/2004
7
Disease Progression
01/2023 - 12/2006
6
Peripheral Nervous System Diseases (PNS Diseases)
09/2022 - 05/2014
6
Diarrhea
01/2021 - 12/2008
5
Residual Neoplasm
01/2024 - 08/2005
3
Neutropenia
01/2021 - 01/2015
3
Noninfiltrating Intraductal Carcinoma (DCIS)
01/2020 - 01/2019
3
Nausea
01/2020 - 12/2008
3
Fatigue
01/2020 - 01/2019
2
Leukemia
10/2023 - 01/2021
2
Amenorrhea
01/2022 - 06/2015
2
Obesity
01/2021 - 01/2021
2
Inflammatory Breast Neoplasms
01/2021 - 05/2012
2
Myalgia
01/2021 - 01/2019
2
Leukopenia
01/2021 - 12/2016
2
Hot Flashes
01/2021 - 01/2020
2
Anemia
01/2021 - 08/2018
2
Body-Weight Trajectory
02/2020 - 01/2018
2
Weight Gain
02/2020 - 01/2018
2
Vomiting
01/2020 - 12/2008
2
Circulating Neoplastic Cells
01/2020 - 01/2017
2
Hemorrhage
07/2019 - 01/2015
Drug/Important Bio-Agent (IBA)
45
Hormones (Hormone)
IBA
03/2024 - 04/2006
38
Estrogen Receptors
IBA
03/2024 - 04/2006
30
Phenobarbital (Luminal)
FDA Link
03/2024 - 10/2005
28
Trastuzumab (Herceptin)
FDA Link
12/2023 - 08/2006
22
ErbB Receptors (EGF Receptor)
IBA
01/2024 - 02/2007
20
human ERBB2 protein
IBA
02/2024 - 04/2008
20
Paclitaxel (Taxol)
FDA Link
Generic
11/2023 - 08/2006
15
Biomarkers (Surrogate Marker)
IBA
01/2023 - 12/2006
15
Progesterone Receptors (Progesterone Receptor)
IBA
01/2022 - 04/2006
14
RNA (Ribonucleic Acid)
IBA
01/2024 - 03/2012
14
DNA (Deoxyribonucleic Acid)
IBA
01/2023 - 08/2009
12
Estrogens (Estrogen)
FDA Link
01/2022 - 04/2006
10
Lapatinib (GW572016)
FDA Link
11/2023 - 12/2007
9
Proteins (Proteins, Gene)
FDA Link
10/2021 - 12/2006
9
Anthracyclines
IBA
01/2021 - 04/2007
6
sacituzumab govitecan
IBA
04/2024 - 01/2021
6
taxane
IBA
09/2022 - 09/2005
6
Carboplatin (JM8)
FDA Link
Generic
01/2022 - 07/2007
6
Bevacizumab (Avastin)
FDA Link
01/2022 - 01/2015
6
Messenger RNA (mRNA)
IBA
01/2022 - 07/2014
5
pertuzumab
IBA
11/2023 - 01/2019
5
Capecitabine (Xeloda)
FDA Link
01/2023 - 01/2018
5
Epidermal Growth Factor (EGF)
IBA
01/2023 - 06/2006
5
Doxorubicin (Adriamycin)
FDA Link
Generic
01/2022 - 09/2005
4
Phosphotransferases (Kinase)
IBA
04/2024 - 06/2009
4
Vinorelbine (Navelbine)
FDA Link
Generic
01/2023 - 10/2018
4
Cyclophosphamide (Cytoxan)
FDA Link
Generic
01/2022 - 08/2006
4
Poly(ADP-ribose) Polymerase Inhibitors
IBA
12/2020 - 01/2010
4
Letrozole (Femara)
FDA Link
Generic
01/2020 - 05/2009
4
Tamoxifen
FDA Link
Generic
11/2017 - 04/2006
4
Enzymes
IBA
11/2017 - 02/2008
3
Immunoconjugates (Immunoconjugate)
IBA
02/2024 - 01/2021
3
Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)
FDA Link
11/2023 - 01/2015
3
APT
IBA
01/2023 - 06/2015
3
tucatinib
IBA
01/2023 - 01/2020
3
Immune Checkpoint Inhibitors
IBA
11/2022 - 09/2017
3
Antigens
IBA
01/2022 - 01/2017
3
Aromatase Inhibitors
IBA
01/2022 - 05/2009
3
Mitogen-Activated Protein Kinase Kinases (MEKs)
IBA
01/2021 - 07/2007
3
Platinum
IBA
01/2021 - 01/2010
3
Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
IBA
01/2020 - 03/2009
3
Coloring Agents (Dyes)
IBA
07/2019 - 09/2005
3
Androgen Receptors (Androgen Receptor)
IBA
08/2018 - 10/2013
3
Cytochrome P-450 CYP2C8
IBA
11/2017 - 07/2012
3
Claudins
IBA
09/2017 - 03/2012
3
Cetuximab (Erbitux)
FDA Link
03/2014 - 07/2007
2
Everolimus
FDA Link
04/2024 - 10/2018
2
Surface Antigens (Surface Antigen)
IBA
02/2024 - 01/2021
2
Fulvestrant (Faslodex)
FDA Link
01/2024 - 01/2022
2
Circulating Tumor DNA
IBA
03/2023 - 04/2014
2
Vaccines
IBA
01/2023 - 01/2022
2
Epitopes
IBA
01/2023 - 07/2014
2
Peptides (Polypeptides)
IBA
01/2023 - 01/2022
2
eribulin
FDA Link
08/2022 - 01/2021
2
Gemcitabine
FDA Link
08/2022 - 01/2021
2
neratinib
IBA
01/2022 - 12/2016
2
Monoclonal Antibodies
IBA
05/2021 - 12/2006
2
Irinotecan (Camptosar)
FDA Link
Generic
01/2021 - 08/2014
2
Topoisomerase I Inhibitors
IBA
01/2021 - 08/2014
2
Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)
IBA
12/2020 - 10/2010
2
Biological Factors
IBA
09/2020 - 01/2013
2
Histone Deacetylase Inhibitors
IBA
01/2019 - 01/2015
2
thiamine triphosphorate (TTP)
IBA
10/2018 - 12/2010
2
Asparagine
IBA
01/2018 - 01/2018
2
Antibodies
IBA
09/2017 - 03/2014
Therapy/Procedure
81
Therapeutics
04/2024 - 09/2002
52
Drug Therapy (Chemotherapy)
04/2024 - 12/2004
35
Neoadjuvant Therapy
03/2024 - 09/2002
7
Adjuvant Chemotherapy
10/2023 - 04/2014
6
Mastectomy (Mammectomy)
12/2022 - 09/2002
5
Immunotherapy
01/2023 - 09/2004
5
Radiotherapy
12/2022 - 11/2005
2
Continuity of Patient Care
09/2020 - 11/2019